E-LIB Suche - Ergebnisse für: Gbandi, Emma

1

The ABCB1 2677G>T/A polymorphism is associated with baselin..:

Agapakis, Dimitris ; Panderi, Athanassia ; Gbandi, Emma...
Hellenic Journal of Cardiology. 59 (2018) 2 - p. 122-126 , 2018

Link: https://doi.org/10.1016/..

2

Association of the CETP Taq1B and LIPG Thr111Ile Polymorphi..:

Agapakis, Dimitrios ; Savopoulos, Christos ; Kypreos, Kyriakos E....
Canadian Journal of Diabetes. 40 (2016) 6 - p. 515-520 , 2016

Link: https://doi.org/10.1016/..

3

Common ABCB1 polymorphisms in Greek patients with chronic h..:

Gbandi, Emma ; Goulas, Antonis ; Sevastianos, Vassilios...
Pharmacological Reports. 68 (2016) 2 - p. 476-482 , 2016

Link: https://doi.org/10.1016/..

4

Association of the CYP2B6 c.516G>T Polymorphism with High B..:

Mastrogianni, Orthodoxia ; Gbandi, Emma ; Orphanidis, Amvrosios...
Drug Metabolism and Pharmacokinetics. 29 (2014) 2 - p. 215-218 , 2014

Link: https://doi.org/10.2133/..

5

Outcome of azacitidine therapy in acute myeloid leukaemia i..:

Craddock, Charles ; Houlton, Aimee E ; Quek, Lynn Swun...
Craddock , C , Houlton , A E , Quek , L S , Ferguson , P , Gbandi , E , Roberts , C , Metzner , M , Garcia-Martin , N , Kennedy , A , Hamblin , A , Raghavan , M , Nagra , S , Dudley , L , Wheatley , K , McMullin , M , Pillai , S P , kelly , R J , Siddique , S , Dennis , M , Cavenagh , J D & Vyas , P 2017 , ' Outcome of azacitidine therapy in acute myeloid leukaemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature ' , Clinical Cancer Research . https://doi.org/10.1158/1078-0432.CCR-17-1423. , 2017

Link: https://pure.qub.ac.uk/e..

6

Ruxolitinib versus best available therapy for ET intolerant..:

Harrison, Claire N ; Mead, Adam J ; Panchal, A...
Harrison , C N , Mead , A J , Panchal , A , McMullin , M , Fox , S , Yap , C , Gbandi , E , Houlton , A , Alimam , S , Ewing , J , Wood , M , Chen , F , Coppell , J , Panoskaltsis , N , knapper , S , Ali , S , Hmblin , A , Scherber , R , Dueck , A C , Cross , N & Rubin , M 2017 , ' Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomised trial ' , Blood , vol. 130 , no. 17 , pp. 1889 . https://doi.org/10.1182/blood-2017-05-785790. , 2017

Link: https://pure.qub.ac.uk/e..